Biomed Central Ltd

SHERPA: Unknown

People

  1. D'Angelo
    D'Angelo
  2. Shoushtari
    Shoushtari
  3. Schoenfeld
    Schoenfeld
  4. Klebanoff
    Klebanoff
  5. Levine
    Levine
  6. Park
    Park
  7. Tap
    Tap
  8. Stein
    Stein
  9. Voss
    Voss
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (160)
  2. Hematologic Malignancies, Division of (160)
  3. Solid Tumor Oncology Division (99)
  4. Center for Hematologic Malignancies (68)
  5. GSK Faculty (54)
  6. Hematology-Oncology Fellows (49)
  7. Weinberg Fellows (41)
  8. Melanoma and Immunotherapeutics Service (38)
  9. Adult Leukemia (36)
  10. Melanoma Disease Management Team (34)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (86)
  2. Meeting Abstract (58)
  3. Review (7)
  4. Guidelines (6)
  5. Research Letter (2)
  6. Editorial (1)
Groups
  1. Department of Medicine (160)
  2. Hematologic Malignancies, Division of (160)
  3. Solid Tumor Oncology Division (99)
  4. Center for Hematologic Malignancies (68)
  5. GSK Faculty (54)
  6. Hematology-Oncology Fellows (49)

More Groups

People
  1. Sandra D'Angelo (26)
  2. Alexander Shoushtari (21)
  3. Jedd Wolchok (14)
  4. Adam Schoenfeld (11)
  5. Allison Betof Warner (9)
  6. Christopher Klebanoff (8)

More People

Years
  1. 2025 (10)
  2. 2024 (9)
  3. 2023 (7)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (21)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (103)
  2. Journal of Hematology & Oncology (19)
  3. Journal of Translational Medicine (9)
  4. BMC Cancer (4)
  5. Genome Biology (4)
  6. Biomarker Research (2)

More Publications

Results (160)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
    Journal Article

    McMillan, M. T.; Reyngold, M.; Crane, C. H.; O'Brien, D. A. R.; Williams, V. M.; Zinovoy, M.; Cuaron, J. J.; Gönen, M.; Kaiser, A.; Sopka, D. M.; more...
    BMC Cancer (2025)

    Fulltext@MSK | Save
  • Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL
    Journal Article

    Culbert, A. A.; Gava, F.; Valtis, Y. K.; Satta, T.; Vora, S.; Rocco, J. M.; Nussenblatt, V.; Silbert, S. K.; Shalabi, H.; Yates, B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Allele-specific HLA LOH in solid tumors: Distinct patterns by tumor type and potential prognostic relevance
    Journal Article

    Sewastianik, T.; Roy, C.; Gormally, M.; Montesion, M.; Halvey, P.; Jindal, A.; Lam, H.; Schoenfeld, A.; Klebanoff, C. A.; Opiteck, G. J.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
    Journal Article

    Nacev, B. A.; Bradic, M.; Woo, H. J.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: Preclinical investigations to a phase I clinical trial (NCT06623396)
    Journal Article

    Restle, D.; Amador-Molina, A.; Misawa, K.; Banerjee, S.; Ku, G.; Adusumilli, P. S.
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Joint representation and visualization of derailed cell states with Decipher
    Journal Article

    Nazaret, A.; Fan, J. L.; Lavallée, V. P.; Burdziak, C.; Cornish, A. E.; Kiseliovas, V.; Bowman, R. L.; Masilionis, I.; Chun, J.; Eisman, S. E.; more...
    Genome Biology (2025)

    Fulltext@MSK | Save
  • Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML
    Journal Article

    Ball, B. J.; Xiao, W.; Borthakur, G.; Nguyen, L. X. T.; Valerio, M.; Venkatachalam, A.; Marcucci, G.; Stein, A. S.; Thai, D. L.; Cook, D. N.; more...
    Journal of Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Journal Article

    Middha, P.; Thummalapalli, R.; Quandt, Z.; Balaratnam, K.; Cardenas, E.; Falcon, C. J.; Princess Margaret Lung Group; Gubens, M. A.; Huntsman, S.; Khan, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: Subgroup analyses from the CIBMTR registry
    Journal Article

    Landsburg, D. J.; Frigault, M. J.; Heim, M.; Foley, S. R.; Hill, B.; Schofield, G.; Jacobson, C. A.; Jaglowski, S.; Locke, F. L.; Ram, R.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save